RACHEL ROHAIDY: Open Payments
NPI 1730475823 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 21 payments from 6 companies in 2025. Trend: 2023 $433 · 2024 $629 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $176 |
| Corium, LLC | 9 | $88 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Neos Therapeutics, LP | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, Azstarys, Jornay PM, Adzenys XR-ODT, INGREZZA, Auvelity.
Industry payments across FL — which companies pay providers there.
